About this trial
The objective of this study is to investigate "clinically" the effectiveness of Glycyrrhizin based intracanal medication compared to the commonly used intracanal medicaments (calcium hydroxide Ca(OH)2 and Ledermix) on the levels of bacteria and inflammatory cytokines in root canals and periradicular tissues of teeth with apical periodontitis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Single-rooted with pulp necrosis and apical periodontitis.
Disqualifiers
Receiving antibiotic treatment within the preceding 3 months.
Reporting systemic disease.
Teeth that could not be isolated with rubber dam.
Teeth with periodontal pockets deeper than 3 mm.
Trial design
Crossover
Treatments tested in this trial
Calcium Hydroxide
DrugIntracanal medication
Leddermix
DrugIntracanal medication
Glycirrhizin
DrugIntracanal medication
Treatment groups
Trial outcomes
Primary outcomes
counting the number of colonies forming units of bacterial cells
Microbiology cell culturing (manual counting technique to the bacterial cells)
Other outcomes
using enzyme-linked immunosorbent assay (ELISA test) to measure the amount of Inflammatory Cytokines (TNF-α), (IL-1β) and (PG2)
ELISA test to measure the amount of tumor necrotizing factor (TNF-α), interleukin 1β(IL-1β) and prostaglandin E2 (PG2)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.